nylidrin has been researched along with Cardiovascular Stroke in 3 studies
Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Köenig, FK | 1 |
| Gasic, S | 1 |
| Probst, P | 1 |
| Karpman, HL | 1 |
| Okun, R | 1 |
1 trial available for nylidrin and Cardiovascular Stroke
| Article | Year |
|---|---|
The effect of vasodilating drugs in peripheral vascular disease.
Topics: Aged; Arteriosclerosis Obliterans; Cardiac Output; Clinical Trials as Topic; Diabetes Mellitus; Diab | 1972 |
2 other studies available for nylidrin and Cardiovascular Stroke
| Article | Year |
|---|---|
Acral diagnosis and possibilities of conservative treatment of chronic obstructive vascular diseases.
Topics: Adult; Angiography; Arterial Occlusive Diseases; Contraceptives, Oral, Hormonal; Female; Humans; Myo | 1983 |
[Prinzmetal angina].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arterial Occlus | 1975 |